Chorioamnionitis in utero, schizophrenia in adulthood: limited current evidence-future research focus?

J Matern Fetal Neonatal Med. 2022 Dec;35(24):4782-4787. doi: 10.1080/14767058.2020.1863370. Epub 2021 Jan 12.

Abstract

Background: Developmental adaptive processes during gestation that are known to be involved in permanent changes in physiology and metabolism or "early life programming" can adversely affect fetal brain development, impacting both brain structure and function.Data: Emerging evidence strongly supports the developmental origin of schizophrenia, which may potentially be a result of prenatal exposure to a diversity of factors, especially infections, in genetically predisposed subjects. Structural and functional brain changes during development of schizophrenia are determined by genetic components, altered expression of schizophrenia risk genes and epigenetic dysregulation. However, the precise mechanisms underlying these relationships remain unclear. Findings from human and animal studies suggest that inflammatory-immune responses and activation of oxidative stress pathways are crucial in mediating intrauterine infection-induced neurodevelopmental and neuropsychiatric diseases.Aim: Considering the high prevalence of intrauterine inflammation in the context of chorioamnionitis during human pregnancy and the paucity of knowledge on fetal programming of schizophrenia, this mini review aims to exclusively consolidate the current evidence supporting a potential association between chorioamnionitis and schizophrenia.

Keywords: Chorioamnionitis; developmental origins of health and disease; fetal/early life programming; intrauterine infection/inflammation; neuropsychiatric disorders; schizophrenia.

Publication types

  • Review

MeSH terms

  • Adult
  • Animals
  • Brain / metabolism
  • Chorioamnionitis* / metabolism
  • Female
  • Fetal Development / physiology
  • Humans
  • Inflammation
  • Pregnancy
  • Schizophrenia* / epidemiology
  • Schizophrenia* / genetics